Avenue Therapeutics Inc. (ATXI)
NASDAQ · Healthcare
Avenue Therapeutics Inc. Shareholder Equity 2024–2025
Avenue Therapeutics Inc. annual/quarterly shareholder equity history from 2024 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Avenue Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 1.8M, a 34.50% decrease year-over-year.
- Avenue Therapeutics Inc. shareholder equity for 2025 were 1.8M, a 34.50% decrease from 2024.
- Avenue Therapeutics Inc. shareholder equity for 2024 were 2.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Avenue Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $2 |
| 2024 | $3 |
| Avenue Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $2 |
| 2024-12-31 | $3 |
Avenue Therapeutics Inc. Shareholder Equity — FAQ
Avenue Therapeutics Inc. (ATXI) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATXI's shareholder equity history?
The chart and table above show Avenue Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.